首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >A validated LC-MS/MS assay for the simultaneous determination of periplocin and its two metabolites, periplocymarin and periplogenin in rat plasma: Application to a pharmacokinetic study
【24h】

A validated LC-MS/MS assay for the simultaneous determination of periplocin and its two metabolites, periplocymarin and periplogenin in rat plasma: Application to a pharmacokinetic study

机译:用于同时测定大鼠血浆中骨膜白蛋白及其两种代谢物,骨膜上腺素和骨膜生成素的经过验证的LC-MS / MS分析:在药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A sensitive and reliable LC-MS/MS method was developed and validated for the simultaneous determination of periplocin and its two metabolites (periplocymarin and periplogenin) in rat plasma using psoralen as the internal standard (IS). After liquid-liquid extraction with ethyl acetate, chromatographic separation was performed on a C18 column with a 13 min gradient elution using 0.1% formic acid and acetonitrile as mobile phase at a flow rate of 0.3 mL/min. The detection was accomplished on a tandem mass spectrometer via an electrospray ionization (ESI) source by multiple reaction monitoring (MRM) in the positive ionization mode. The lower limits of quantitation (LLOQs) for periplocin, periplocymarin and periplogenin were 0.5, 1 and 0.1 ng/mL, respectively. The mean recoveries of the analytes and IS were higher than 67.7%. The proposed method was successfully applied to evaluating the pharmacokinetic studies of periplocin and its metabolites (periplocymarin and periplogenin) in rats after a single oral administration of periplocin at 50 mg/kg. (C) 2015 Elsevier B.V. All rights reserved.
机译:开发了一种灵敏而可靠的LC-MS / MS方法,并以补骨脂素作为内标(IS)同时测定了大鼠血浆中的骨膜素及其两种代谢产物(periplocymarin和periplogeninin),并进行了验证。用乙酸乙酯液-液萃取后,在C18色谱柱上进行色谱分离,使用0.1%甲酸和乙腈作为流动相,以0.3 mL / min的流速进行13分钟的梯度洗脱。该检测是在串联质谱仪上通过电喷雾电离(ESI)源通过正电离模式下的多反应监测(MRM)完成的。骨膜黏附素,骨膜黏附素和骨膜黏附素的定量下限(LLOQs)分别为0.5、1和0.1 ng / mL。分析物和IS的平均回收率均高于67.7%。所建议的方法已成功地用于评估口服口服50mg / kg的骨膜黏附素及其代谢产物(periplocymarin和骨膜黏附素)的药代动力学研究。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号